-
公开(公告)号:EP1027351A1
公开(公告)日:2000-08-16
申请号:EP98967153.2
申请日:1998-10-26
申请人: FIBROGEN, INC. , ZENECA LIMITED
发明人: EDWARDS, Philip Neil , LARGE, Michael Stewart , HALES, Neil, James , MARTIN, George, R. , HUANG, Xinfan
IPC分类号: C07D471/04
CPC分类号: C07D471/04 , A61K31/4745
摘要: The present invention provides a phenanthroline derivative of formula (I) wherein, for example, R1 is hydrogen, carboxy, cyano, nitro, (1-4C)alkyl, (1-6C)alkoxycarbonyl, (1-4C)alkylamino, (2-4C)alkanoyl, (1-4C)alkoxy-(2-4C)alkoxy-(2-4C)alkoxycarbonyl or N-[amino-(2-8C)alkyl]carbamoyl; R2 is, for example, hydrogen, carboxy, (1-6C)alkoxycarbonyl, carbamoyl, N-(1-8C)alkylcarbamoyl, N,N-di-(1-8C)alkylcarbamoyl, N-(1-4C)alkylcyclohexylcarbamoyl, 1,2,3,4,-tetrahydro-isoquinolin-2-ylcarbonyl or N,N-[di-(1-4C)alkyl]thiocarbamoyl; R?3 and R4¿, which may be the same or different, are, for example, hydrogen or halo; and R5 is, for example, hydrogen, di-(1-4C)alkylamino or halo; or a pharmaceutically-acceptable salt thereof. The invention further provides pharmaceutical compositions comprising phenanthroline derivatives, processes for making the same and their use in producing an anti-fibroproliferative effect.
-
公开(公告)号:EP1027351B1
公开(公告)日:2003-12-03
申请号:EP98967153.2
申请日:1998-10-26
申请人: FibroGen, Inc. , Syngenta Limited
发明人: EDWARDS, Philip Neil , LARGE, Michael Stewart , HALES, Neil, James , MARTIN, George, R. , HUANG, Xinfan
IPC分类号: C07D471/04
CPC分类号: C07D471/04 , A61K31/4745
-